Joseph Talamo
Chief Financial Officer
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | $374,696 | $723,739 |
| 2024 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | $370,000 | $1,662,576 |
| 2023 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | $14,231 | $456,371 |
| 2022 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | — | — |
| 2020 | Lisata Therapeutics, Inc. (LSTA) | Former Chief Financial Officer | $223,388 | $495,138 |
| 2019 | Lisata Therapeutics, Inc. (LSTA) | Former Chief Financial Officer | $338,077 | $676,630 |
| 2018 | Lisata Therapeutics, Inc. (LSTA) | Chief Financial Officer | $334,673 | $834,955 |
Executive changes
Earnings-call appearances
-
Second Quarter 2026 Financial Results Conference Call2026-08-11
Intensity Therapeutics, Inc. (INTS)
-
Lisata Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-07
Lisata Therapeutics, Inc. (LSTA)